In this article, we will take a look at Billionaire David Abrams’ Top 9 Stock Picks with Upside Potential.
The magnificent seven mega-cap technology stocks shed more than $2.2 trillion in value in June. The sell-off came amid a violent rotation away from tech companies spending hundreds of billions of dollars on AI infrastructure. Additionally, investors increasingly questioned whether the enormous spending commitments by the so-called hyperscalers would translate into sufficient profits to justify the huge share price gains in recent years.
Rob Haworth, US Bank Asset Management senior investment strategy director, insists the rotation is a critical narrative for investors to watch. “Rotation remains a key theme in this equity market and that is evident,” he said.
According to David Morrison, senior market analyst at Trade Nation, investors are rotating out of overheated semiconductor stocks into some overlooked sectors offering better value. Industrials, healthcare, and consumer cyclical sectors are among those increasingly standing out amid the ongoing rotation away from tech. The prospects of the US Federal Reserve refraining from interest rate hikes are also having a positive impact on the equity market.
Abrams Capital Management is one hedge fund well-positioned to capitalize on the ongoing rotation. Founded in 1999 by billionaire David Abrams, the hedge fund offers significant exposure to industrials and consumer cyclical stocks, which account for the largest share of the portfolio.
The portfolio is highly focused and consistent with Abrams’ long-standing philosophy of deep fundamental research and long-term capital deployment. The billionaire investor has made a name for himself on investing in undervalued businesses with strong asset bases, durable cash flows, and clear paths to value realization.
With that in mind, let’s take a look at some of billionaire David Abrams’ top stock picks with upside amid the broader market rotation.
David Abrams of Abrams Capital Management
Our Methodology
For this list of billionaire David Abrams’ top 9 stock picks with upside potential, we began by analyzing the Q1 2026 13F filings from his hedge fund, Abrams Capital Management. From there, we selected the fund’s top 10 stock picks with positive upside potential. We also reviewed the overall hedge fund sentiment around these stocks using Insider Monkey’s Q1 2026 database. Finally, the stocks were ranked in ascending order based on the value of Abrams Capital Management’s stake in each company.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research shows we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).
Billionaire David Abrams’ Top Stock Picks with Upside Potential
9. Nuvation Bio Inc (NYSE:NUVB)
Abrams Capital Management’s Investment Stake: $5.45 Million
Number of Hedge Fund Holders: 41
Stock Upside Potential: 152.63%
Nuvation Bio Inc (NYSE:NUVB) is one of billionaire David Abrams’ top stock picks with upside potential. Nuvation Bio shares gained nearly 170% over the past year, and analysts project a more than 150% upside for the stock over the next 12 months. Some 41 hedge funds are backing Nuvation Bio stock.
This comes as Nuvation Bio Inc (NYSE:NUVB) works to expand the market for its lung cancer drug. On June 29, Nuvation Bio said that the UK drug regulator had accepted the marketing application for its lung cancer drug and would review the request to decide whether to approve or reject it. The marketing application was submitted by Nuvation Bio’s partner Eisai.
The drug, known as taletrectinib, targets advanced ROS1-positive non-small cell lung cancer. Nuvation Bio has already secured marketing approvals for the drug in the US, Japan, and China. It is seeking the drug’s approval in the UK and other international markets.
In the meantime, Nuvation Bio is shoring up its balance sheet. The company exited Q1 2026 with $533.7 million in ash, cash equivalents, and marketable securities and recently raised $287.5 million through a notes offering.
Nuvation Bio Inc (NYSE:NUVB) is a global biopharmaceutical company focused on developing targeted therapies for cancers. The company aims to address unmet needs in cancer treatment. Its pipeline includes drug candidates targeting lung cancer and gliomas.
8. U-Haul Holding Co (NYSE:UHAL.B)
Abrams Capital Management’s Investment Stake: $145.2 Million
Number of Hedge Fund Holders: 44
Stock Upside Potential: 29.37%
U-Haul Holding Co (NYSE:UHAL.B) is one of billionaire David Abrams’ top stock picks with upside potential. U-Haul shares have gained more than 32% year-to-date, and analysts expect them to keep rising. Some 44 hedge funds have positions on U-Haul stock.
On June 26, U-Haul Holding Co (NYSE:UHAL.B) distributed a quarterly cash dividend of $0.05 per share. There is more to come in terms of shareholder returns for U-Haul investors. The company’s board has determined that the stock is cheap and seized on the opportunity to acquire it at a discount. Consequently, the board has approved a $350 million share repurchase program.
U-Haul CFO Jason Berg described the stock buyback program as a wise allocation of capital considering where the company stands right now. According to the finance chief, at this point the company has invested enough in fleet, storage capacity, and other aspects of the business. This allows the company to slow capital spending to free up funds for the buyback program.
U-Haul exited the March quarter with more than $1 billion in cash and cash equivalents.
U-Haul Holding Co (NYSE:UHAL.B) is a moving and storage provider operating in the US and Canada. It rents out trucks, cargo vans, and utility trailers for do-it-yourself household moving. The company operates a network of self-storage facilities and offers insurance products.
Hedge Fund Resource Center